Trial Profile
A phase II study of low dose interleukin-6 (atexakin alfa) for the treatment of peripheral diabetic neuropathy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs Interleukin-6 (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- 29 Jul 2016 New trial record